The association of a number of predictive factors for the recurrence of papillary urothelial neoplasm of low malignant potential: Prognostic analysis from multiple academic centers.
暂无分享,去创建一个
Seung Hwan Lee | K. Koo | S. Hong | B. Chung | Ki Hong Kim | W. Bang | J. Cho | J. Park | S. I. Kim
[1] Xinke Zhang,et al. Bladder papillary urothelial neoplasm of low malignant potential in Chinese: a clinical and pathological analysis. , 2015, International journal of clinical and experimental pathology.
[2] K. Trpkov,et al. Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth , 2015, Diagnostic Pathology.
[3] M. A. Montironi,et al. Recurrent papillary urothelial neoplasm of low malignant potential. Subtle architectural disorder detected by quantitative analysis in DAXX-immunostained tissue sections. , 2014, Human pathology.
[4] Zhongqing Chen,et al. The 1973 WHO Classification Is More Suitable than the 2004 WHO Classification for Predicting Prognosis in Non-Muscle-Invasive Bladder Cancer , 2012, PloS one.
[5] J. Epstein,et al. Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center. , 2011, Human pathology.
[6] R. Montironi,et al. Global Acetylation and Methylation Changes Predict Papillary Urothelial Neoplasia of Low Malignant Potential Recurrence: A Quantitative Analysis , 2011, International journal of immunopathology and pharmacology.
[7] Chin-Chen Pan,et al. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. , 2010, American journal of clinical pathology.
[8] J. Epstein,et al. Non‐invasive papillary urothelial neoplasms: The 2004 WHO/ISUP classification system , 2010, Pathology international.
[9] G. Thalmann. Organ preservation for T1G3 bladder cancer: is it feasible? , 2008, European urology.
[10] A. Lopez‐Beltran,et al. Morphological diagnosis of urothelial neoplasms , 2007, Journal of Clinical Pathology.
[11] Peter H. Bartels,et al. Chromatin Phenotype Karyometry Can Predict Recurrence in Papillary Urothelial Neoplasms of Low Malignant Potential , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[12] Liang Cheng,et al. Histologic grading of noninvasive papillary urothelial neoplasms. , 2007, European urology.
[13] Liang Cheng,et al. Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts. , 2006, The Journal of urology.
[14] J Alfred Witjes,et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. , 2006, European urology.
[15] P H Bartels,et al. Karyometry detects subvisual differences in chromatin organisation state between non-recurrent and recurrent papillary urothelial neoplasms of low malignant potential , 2004, Journal of Clinical Pathology.
[16] K. Kihara,et al. Long‐term outcome of bladder papillary urothelial neoplasms of low malignant potential , 2003, BJU international.
[17] A. Formiconi,et al. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder , 2002, Cancer.
[18] Lawrence D. True,et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder , 1998 .
[19] F. Mostofi,et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. , 1998, The American journal of surgical pathology.